Viatris: a trusted partner of Vietnamese healthcare community

Formed in November 2020, Viatris brings together scientific, manufacturing and distribution expertise with proven regulatory, medical, and commercial capabilities to deliver high-quality medicines to patients in more than 165 countries and territories. Viatris' portfolio comprises more than 1,400 approved molecules across a wide range of therapeutic areas, spanning both non-communicable and infectious diseases, including globally recognised brands, complex generic and branded medicines, and a variety of over-the-counter consumer products. With more than 38,000 colleagues globally, Viatris is headquartered in the US, with global centres in Pittsburgh, Shanghai and Hyderabad, India.

In Vietnam, Viatris has an extensive diversified portfolio of originator and generic medicines spanning many therapeutic areas to meet nearly every health need, including cardiovascular, pain, central nervous system, men’s health, oncology, dermatology, women’s health and Covid-19 drugs. We also make continued efforts to expand our portfolio through technology transfer of Off-Patent Originators.

We have just celebrated our second anniversary in Vietnam with two offices located in Ho Chi Minh and Hanoi and a warehouse in Long An province. This shows the extension of the company’s global impact and strengthens its commitment to being a trusted partner of the Vietnamese healthcare community. Our business and operating model is deliberately designed and implemented to deliver on our strategy to build and sustain access to medicine at scale. Access to medicine begins with sustainably delivering high-quality medicines and health solutions to people, regardless of geography or circumstance.

We partner with medical associations, hospitals, and some big pharmacy chains to optimise treatment protocols, support healthcare professionals regarding prevention, diagnosis, and treatment options, and to increase patient’s access to high-quality prescription medicines in both NCD and infectious diseases.

Our relentless pursuit is to improve access and support a sustainable healthcare system in Vietnam. This is evident by our commitment to providing high-quality made medicines through a balance of global, regional and local manufacturing as well as our investment in building local expertise and capacity. We hope that our Lotus project, one of the first innovative drug production technology transfer projects in Vietnam, started in 2017, will gain further support from the government, and relevant ministries. We believe that it aligns with the government’s Decision 376; specifically, promoting technology transfer into Vietnam to contribute to self-sufficiency, increased expertise, and fostering the economy of Vietnam.

Viatris Vietnam launches new office in Hanoi Viatris Vietnam Co., Ltd. has celebrated its first anniversary and marked the expansion of its commercial footprint by opening a new office in Hanoi.

Viatris inks partnership with Medochemie to boost manufacturing in Vietnam Viatris Inc., a global healthcare company, announced on December 16 that it is broadening its partnership with Medochemie, a Cyprus-based pharma company, to manufacture its innovative products in Vietnam and improve patient access to high-quality locally manufactured medicines.

Viatris determined to address healthcare needs holistically Global healthcare company Viatris is extending its global impact and further strengthening a firm commitment as a trusted partner of the Vietnamese healthcare community. Eunice Cho, Viatris country manager in Vietnam, talked to VIR’s Minh Anh about the strategy to contribute more.